Alzprotect reçoit une subvention de la Fondation Michael J. Fox pour le développement de l’AZP2006 dans la maladie de Parkinson.
Transgene Presented Additional Phase I Data
with TG4050 (myvac® platform) at ASCO 2022
Enterome presents proof-of-concept immune response data and first clinical data from Phase 1/2 trial with EO2401, a first-in-class OncoMimics™ therapeutic cancer vaccine for adrenocortical carcinoma, at ASCO 2022
Transgene Presented Additional Phase I Data with TG4050 (myvac® platform) at ASCO 2022
